NKp46 ligands were shown to be expressed on human benign and malignant melanocytic lesions (178), but NKp46 and NKp30 ligands were only found on primary human prostate tumors and not benign prostate hyperplasia (179). The gene discussed is NCR1; the disease is benign prostatic hyperplasia.